RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
RT @JavierdeJuan1: Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer -…
RT @clara_clarais: JACC: como prevenir la cardiotoxicidad en CA de mama, miren los números!!! Cifras alarmantes de toxicidad Randomized T…
RT @UmutKocabasMD: HER2+ meme kanseri olan ve transtuzumab + antrasiklin tedavisi gören kadınlarda gerek lisinopril, gerek ise karvedilolün…
HER2+ meme kanseri olan ve transtuzumab + antrasiklin tedavisi gören kadınlarda gerek lisinopril, gerek ise karvedilolün kardiyotoksisite prevensiyonu açısından plaseboya üstün olduğu gösterildi. https://t.co/vWrmq4kHcR
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
アントラサイクリン系抗がん剤投与歴のある乳がん患者におけるトラスツズマブ使用例に対するACE-Iやβ遮断薬の予防効果!
RT @HeitnerStephen: #cardioonc cardioprotection works! Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxic…
RT @gonzaeperez: PREVENCIÓN DE CARDIOTOXICIDAD POR TRASTUZUMAB En ca de mama tratados con #Trastuzumab. Parece que administrar #Lisinopril…
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
Will we be bringing #Lisinopril & #carvedilol to the preventative discussions on #Oncology wards? Recent data explores their utility in preventing #anthracycline-related #cardiotoxicity in #trastuzumab related #breastcancer. @acog @AmericanCancer @JAC
RT @JavierdeJuan1: Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer -…
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
RT @JavierdeJuan1: Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer -…
Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer - ScienceDirect https://t.co/wBtziTXuRW
RT @clara_clarais: JACC: como prevenir la cardiotoxicidad en CA de mama, miren los números!!! Cifras alarmantes de toxicidad Randomized T…
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
RT @clara_clarais: JACC: como prevenir la cardiotoxicidad en CA de mama, miren los números!!! Cifras alarmantes de toxicidad Randomized T…
RT @gonzaeperez: PREVENCIÓN DE CARDIOTOXICIDAD POR TRASTUZUMAB En ca de mama tratados con #Trastuzumab. Parece que administrar #Lisinopril…
#cardioonc cardioprotection works! Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer https://t.co/aWPmhpJfhI
JACC: como prevenir la cardiotoxicidad en CA de mama, miren los números!!! Cifras alarmantes de toxicidad Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer https://t.co/QWoKGYgEnG https
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
RT @gonzaeperez: PREVENCIÓN DE CARDIOTOXICIDAD POR TRASTUZUMAB En ca de mama tratados con #Trastuzumab. Parece que administrar #Lisinopril…
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
RT @JACCJournals: Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.c…
Can lisinopril and carvedilol prevent cardiotoxicity of anthracyclines in trastuzumab-treated breast #cancer? https://t.co/4yMWJXqwtR #JACC @MGuglin https://t.co/CWhGCuKek4
RT @md_arianemacedo: Important data published today about cardioprotection strategies in BC patients. Randomized Trial of Lisinopril Versus…
RT @CardiOncoSAC: 📌👍🏻Randomized Trial & cardioproteccion. Lisinopril Versus Carvedilol en pacientes con cancer de mama tratada…
RT @gambarte_jimena: 💪🏻 ! X mas evidencia en Cardio oncología https://t.co/tlLThUynaQ https://t.co/seYI5fFL7T
RT @CardiOncoSAC: 📌👍🏻Randomized Trial & cardioproteccion. Lisinopril Versus Carvedilol en pacientes con cancer de mama tratada…
RT @CardiOncoSAC: 📌👍🏻Randomized Trial & cardioproteccion. Lisinopril Versus Carvedilol en pacientes con cancer de mama tratada…
RT @gonzaeperez: PREVENCIÓN DE CARDIOTOXICIDAD POR TRASTUZUMAB En ca de mama tratados con #Trastuzumab. Parece que administrar #Lisinopril…
RT @CardiOncoSAC: 📌👍🏻Randomized Trial & cardioproteccion. Lisinopril Versus Carvedilol en pacientes con cancer de mama tratada…
RT @Office_j: 【ACE阻害薬、ベータ遮断薬によるトラスツズマブ心毒性抑制確認できず:RCT/ JACC】 HER2陽性乳癌468例ランダム化:トラスツズマブ開始時からのACE阻害薬、あるいはβ遮断薬1年間服用で、心機能非低下 [EF低下10%未満] 生存率はプラ…
RT @gonzaeperez: PREVENCIÓN DE CARDIOTOXICIDAD POR TRASTUZUMAB En ca de mama tratados con #Trastuzumab. Parece que administrar #Lisinopril…
RT @gonzaeperez: PREVENCIÓN DE CARDIOTOXICIDAD POR TRASTUZUMAB En ca de mama tratados con #Trastuzumab. Parece que administrar #Lisinopril…
RT @md_arianemacedo: Important data published today about cardioprotection strategies in BC patients. Randomized Trial of Lisinopril Versus…
RT @md_arianemacedo: Important data published today about cardioprotection strategies in BC patients. Randomized Trial of Lisinopril Versus…
RT @md_arianemacedo: Important data published today about cardioprotection strategies in BC patients. Randomized Trial of Lisinopril Versus…
RT @md_arianemacedo: Important data published today about cardioprotection strategies in BC patients. Randomized Trial of Lisinopril Versus…
RT @CardiOncoSAC: 📌👍🏻Randomized Trial & cardioproteccion. Lisinopril Versus Carvedilol en pacientes con cancer de mama tratada…
RT @md_arianemacedo: Important data published today about cardioprotection strategies in BC patients. Randomized Trial of Lisinopril Versus…
ACE vs B bloq to prevent cardiotoxicity for trastuzumab!
💪🏻 ! X mas evidencia en Cardio oncología https://t.co/seYI5fFL7T
📌👍🏻Randomized Trial & cardioproteccion. Lisinopril Versus Carvedilol en pacientes con cancer de mama tratadas con Trastuzumab https://t.co/ory923uqEh
RT @md_arianemacedo: Important data published today about cardioprotection strategies in BC patients. Randomized Trial of Lisinopril Versus…
RT @MGuglin: Our trial is published on herceptin cardiotoxicity prevention. Herceptin and anthracyclin cardiomyopathy respond differently t…
RT @gonzaeperez: PREVENCIÓN DE CARDIOTOXICIDAD POR TRASTUZUMAB En ca de mama tratados con #Trastuzumab. Parece que administrar #Lisinopril…
RT @md_arianemacedo: Important data published today about cardioprotection strategies in BC patients. Randomized Trial of Lisinopril Versus…
RT @md_arianemacedo: Important data published today about cardioprotection strategies in BC patients. Randomized Trial of Lisinopril Versus…
Always wondered what to do with these folks... Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzuma... https://t.co/C6NWhT4UZA
🤔
RT @md_arianemacedo: Important data published today about cardioprotection strategies in BC patients. Randomized Trial of Lisinopril Versus…
RT @gonzaeperez: PREVENCIÓN DE CARDIOTOXICIDAD POR TRASTUZUMAB En ca de mama tratados con #Trastuzumab. Parece que administrar #Lisinopril…
RT @gonzaeperez: PREVENCIÓN DE CARDIOTOXICIDAD POR TRASTUZUMAB En ca de mama tratados con #Trastuzumab. Parece que administrar #Lisinopril…
RT @md_arianemacedo: Important data published today about cardioprotection strategies in BC patients. Randomized Trial of Lisinopril Versus…
RT @md_arianemacedo: Important data published today about cardioprotection strategies in BC patients. Randomized Trial of Lisinopril Versus…
RT @md_arianemacedo: Important data published today about cardioprotection strategies in BC patients. Randomized Trial of Lisinopril Versus…
RT @md_arianemacedo: Important data published today about cardioprotection strategies in BC patients. Randomized Trial of Lisinopril Versus…
RT @md_arianemacedo: Important data published today about cardioprotection strategies in BC patients. Randomized Trial of Lisinopril Versus…
RT @md_arianemacedo: Important data published today about cardioprotection strategies in BC patients. Randomized Trial of Lisinopril Versus…
Important data published today about cardioprotection strategies in BC patients. Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer https://t.co/8SAw8Jx2YW
RT @Office_j: 【ACE阻害薬、ベータ遮断薬によるトラスツズマブ心毒性抑制確認できず:RCT/ JACC】 HER2陽性乳癌468例ランダム化:トラスツズマブ開始時からのACE阻害薬、あるいはβ遮断薬1年間服用で、心機能非低下 [EF低下10%未満] 生存率はプラ…
RT @gonzaeperez: PREVENCIÓN DE CARDIOTOXICIDAD POR TRASTUZUMAB En ca de mama tratados con #Trastuzumab. Parece que administrar #Lisinopril…
RT @gonzaeperez: PREVENCIÓN DE CARDIOTOXICIDAD POR TRASTUZUMAB En ca de mama tratados con #Trastuzumab. Parece que administrar #Lisinopril…
RT @gonzaeperez: PREVENCIÓN DE CARDIOTOXICIDAD POR TRASTUZUMAB En ca de mama tratados con #Trastuzumab. Parece que administrar #Lisinopril…
RT @gonzaeperez: PREVENCIÓN DE CARDIOTOXICIDAD POR TRASTUZUMAB En ca de mama tratados con #Trastuzumab. Parece que administrar #Lisinopril…
RT @avirupguha: Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer https…
RT @gonzaeperez: PREVENCIÓN DE CARDIOTOXICIDAD POR TRASTUZUMAB En ca de mama tratados con #Trastuzumab. Parece que administrar #Lisinopril…
RT @avirupguha: Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer https…
RT @gonzaeperez: PREVENCIÓN DE CARDIOTOXICIDAD POR TRASTUZUMAB En ca de mama tratados con #Trastuzumab. Parece que administrar #Lisinopril…
RT @gonzaeperez: PREVENCIÓN DE CARDIOTOXICIDAD POR TRASTUZUMAB En ca de mama tratados con #Trastuzumab. Parece que administrar #Lisinopril…
RT @gonzaeperez: PREVENCIÓN DE CARDIOTOXICIDAD POR TRASTUZUMAB En ca de mama tratados con #Trastuzumab. Parece que administrar #Lisinopril…
PREVENCIÓN DE CARDIOTOXICIDAD POR TRASTUZUMAB En ca de mama tratados con #Trastuzumab. Parece que administrar #Lisinopril o #Carvedilol podría prevenir la Cardiotoxicidad. Vía @JACCJournals #cardiotwitter https://t.co/c2JVYUHFbA https://t.co/0J0iT1qpcL
RT @Office_j: 【ACE阻害薬、ベータ遮断薬によるトラスツズマブ心毒性抑制確認できず:RCT/ JACC】 HER2陽性乳癌468例ランダム化:トラスツズマブ開始時からのACE阻害薬、あるいはβ遮断薬1年間服用で、心機能非低下 [EF低下10%未満] 生存率はプラ…
RT @Office_j: 【ACE阻害薬、ベータ遮断薬によるトラスツズマブ心毒性抑制確認できず:RCT/ JACC】 HER2陽性乳癌468例ランダム化:トラスツズマブ開始時からのACE阻害薬、あるいはβ遮断薬1年間服用で、心機能非低下 [EF低下10%未満] 生存率はプラ…
RT @avirupguha: Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer https…
RT @avirupguha: Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer https…
RT @Office_j: 【ACE阻害薬、ベータ遮断薬によるトラスツズマブ心毒性抑制確認できず:RCT/ JACC】 HER2陽性乳癌468例ランダム化:トラスツズマブ開始時からのACE阻害薬、あるいはβ遮断薬1年間服用で、心機能非低下 [EF低下10%未満] 生存率はプラ…
【ACE阻害薬、ベータ遮断薬によるトラスツズマブ心毒性抑制確認できず:RCT/ JACC】 HER2陽性乳癌468例ランダム化:トラスツズマブ開始時からのACE阻害薬、あるいはβ遮断薬1年間服用で、心機能非低下 [EF低下10%未満] 生存率はプラセボと有意差なし。 https://t.co/Z5FBqd0yUV https://t.co/gD8L5kEj3F
RT @MGuglin: Our trial is published on herceptin cardiotoxicity prevention. Herceptin and anthracyclin cardiomyopathy respond differently t…
RT @MGuglin: Our trial is published on herceptin cardiotoxicity prevention. Herceptin and anthracyclin cardiomyopathy respond differently t…
RT @MGuglin: Our trial is published on herceptin cardiotoxicity prevention. Herceptin and anthracyclin cardiomyopathy respond differently t…
RT @MGuglin: Our trial is published on herceptin cardiotoxicity prevention. Herceptin and anthracyclin cardiomyopathy respond differently t…
RT @avirupguha: Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer https…
RT @MGuglin: Our trial is published on herceptin cardiotoxicity prevention. Herceptin and anthracyclin cardiomyopathy respond differently t…
RT @avirupguha: Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer https…
RT @MGuglin: Our trial is published on herceptin cardiotoxicity prevention. Herceptin and anthracyclin cardiomyopathy respond differently t…
Our trial is published on herceptin cardiotoxicity prevention. Herceptin and anthracyclin cardiomyopathy respond differently to pharmacologic prevention- our discovery! https://t.co/qmGXw44kYs
RT @avirupguha: Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer https…